Literature DB >> 16362353

[Current treatment for dry eye syndrome].

C Cursiefen1, C Jacobi, T Dietrich, F E Kruse.   

Abstract

The therapy of dry eye disease as a chronic problem necessitates a long-term therapeutic association between patient and ophthalmologist. The aim of therapy is to relieve symptoms and improve vision as far as possible with an acceptable level of effort on the part of the patient. Therapy of dry eye follows a staged concept including tear replacement, serum eye drops, punctum plugs, novel anti-inflammatory drugs (cyclosporin A), and surgical procedures. Interdisciplinary care, especially of patients with autoimmune disease, is recommended and is best provided in a specialized dry eye outpatient clinic with quality control.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16362353     DOI: 10.1007/s00347-005-1300-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  26 in total

Review 1.  Sex steroids, the meibomian gland and evaporative dry eye.

Authors:  D A Sullivan; H Yamagami; M Liu; R J Steagall; F Schirra; T Suzuki; K L Krenzer; J M Cermak; R M Sullivan; S M Richards; D A Schaumberg; M R Dana; B D Sullivan
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

Review 2.  The tear film complex: pathogenesis and emerging therapies for dry eyes.

Authors:  Ronald E Smith
Journal:  Cornea       Date:  2005-01       Impact factor: 2.651

3.  [Blepharitis. Demodex folliculorum, associated pathogen spectrum and specific therapy].

Authors:  M Demmler; H M de Kaspar; C Möhring; V Klauss
Journal:  Ophthalmologe       Date:  1997-03       Impact factor: 1.059

4.  Androgen control of gene expression in the mouse meibomian gland.

Authors:  Frank Schirra; Tomo Suzuki; Stephen M Richards; Roderick V Jensen; Meng Liu; Michael J Lombardi; Patricia Rowley; Nathaniel S Treister; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

5.  The eicosanoid, 15-(S)-HETE, stimulates secretion of mucin-like glycoprotein by the corneal epithelium.

Authors:  R S Jackson ; S J Van Dyken; M D McCartney; J L Ubels
Journal:  Cornea       Date:  2001-07       Impact factor: 2.651

6.  Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.

Authors:  F Brignole; P J Pisella; M De Saint Jean; M Goldschild; A Goguel; C Baudouin
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-01       Impact factor: 4.799

7.  The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study.

Authors:  Takashi Kojima; Reiko Ishida; Murat Dogru; Eiki Goto; Yukihiro Matsumoto; Minako Kaido; Kazuo Tsubota
Journal:  Am J Ophthalmol       Date:  2005-02       Impact factor: 5.258

Review 8.  Diquafosol tetrasodium: a novel dry eye therapy.

Authors:  Kelly K Nichols; Ben Yerxa; Donald J Kellerman
Journal:  Expert Opin Investig Drugs       Date:  2004-01       Impact factor: 6.206

9.  The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.

Authors:  Avni Murat Avunduk; Mustafa Cihat Avunduk; Emily D Varnell; Herbert E Kaufman
Journal:  Am J Ophthalmol       Date:  2003-10       Impact factor: 5.258

Review 10.  Dry eye diagnosis and management in 2004.

Authors:  Henry D Perry; Eric D Donnenfeld
Journal:  Curr Opin Ophthalmol       Date:  2004-08       Impact factor: 3.761

View more
  7 in total

Review 1.  [Descemet's stripping with automated endothelial keratoplasty (DSAEK)].

Authors:  C Cursiefen; F E Kruse
Journal:  Ophthalmologe       Date:  2008-02       Impact factor: 1.059

2.  [Diagnosis of dry eye disease].

Authors:  C Jacobi; E M Messmer
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

Review 3.  [Albumin eye drops for treatment of ocular surface diseases].

Authors:  J D Unterlauft; M Kohlhaas; I Hofbauer; K Kasper; G Geerling
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

4.  [Glaucoma and dry eye. Current concepts and future perspectives].

Authors:  P Steven; C Cursiefen
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

Review 5.  [Dry eye syndrome and neurotrophic keratitis in childhood. Causes and therapy].

Authors:  T Dietrich; A B Renner; H Helbig; I M Oberacher-Velten
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

Review 6.  [Ocular involvement in connective tissue diseases and vasculitides].

Authors:  C Deuter; I Kötter
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

7.  [Manufacture of autologous serum eye drops for out-patient therapy : cooperation between ophthalmic clinic and transfusion medicine department].

Authors:  T Dietrich; V Weisbach; B Seitz; C Jacobi; F E Kruse; R Eckstein; C Cursiefen
Journal:  Ophthalmologe       Date:  2008-11       Impact factor: 1.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.